MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico

The poor immune response elicited by trivalent influenza vaccines (TIVs) in children can be enhanced by the addition of adjuvants. This observer-blind, randomized Phase III trial assessed the immunogenicity and safety of the MF59-adjuvanted trivalent influenza vaccine FLUAD® (aTIV) and a non-adjuvan...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruz-Valdez, Aurelio, Valdez-Zapata, Gabriel, Patel, Sanjay S., Castelli, Flavia V., Garcia, Marcia G., Jansen, Wim T., Arora, Ashwani Kumar, Heijnen, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806633/
https://www.ncbi.nlm.nih.gov/pubmed/28925801
http://dx.doi.org/10.1080/21645515.2017.1373227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806633/
https://www.ncbi.nlm.nih.gov/pubmed/28925801
http://dx.doi.org/10.1080/21645515.2017.1373227

Ejemplares similares